title: In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
authors: Inserm U 25, Hôpital Necker, Paris, France.
authors: S
authors: S
authors: Caillat-Zucman
authors: C
authors: C
authors: Legendre
authors: L H
authors: LH
authors: Noel
authors: J F
authors: JF
authors: Bach
authors: H
authors: H
authors: Kreis
authors: L
authors: L
authors: Chatenoud
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D015703:Antigens, CD / Q000032:analysis; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D017252:CD3 Complex; D005455:Fluorescent Antibody Technique; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation / Q000276:immunology*; D008212:Lymphocyte Depletion; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell / Q000032:analysis; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D014184:Transplantation, Homologous
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D017252:CD3 Complex; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell